Eui Ho Kim Selected Research

Eui Ho Kim Research Topics

Disease

7	Infections 10/2023 - 05/2011
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2008 - 07/2002
4	Leukemia 12/2004 - 03/2003
3	Neoplasms (Cancer) 01/2023 - 05/2002
3	Hematologic Neoplasms (Hematological Malignancy) 01/2008 - 05/2002
2	COVID-19 01/2023 - 11/2022
2	Virus Diseases (Viral Diseases) 09/2012 - 05/2011
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2004 - 11/2003
2	Residual Neoplasm 11/2003 - 03/2003
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2003 - 05/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2003 - 05/2002
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2003 - 05/2002
1	Bites and Stings (Sting) 12/2021
1	Communicable Diseases (Infectious Diseases) 11/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Necrosis 01/2019
1	Human Influenza (Influenza) 08/2007
1	Acute Promyelocytic Leukemia 12/2006
1	Pneumonia (Pneumonitis) 12/2004
1	Blast Crisis (Blast Phase) 03/2003
1	Bronchiolitis Obliterans Syndrome 07/2002
1	Lung Neoplasms (Lung Cancer) 07/2002
1	Disease Progression 05/2002
1	Refractory Anemia with Excess of Blasts (RAEM) 05/2002
1	Refractory Anemia 05/2002

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2023 - 05/2002
4	Tacrolimus (Prograf)FDA LinkGeneric 01/2008 - 07/2002
3	Antiviral Agents (Antivirals)IBA 10/2023 - 03/2022
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2008 - 12/2004
3	fludarabineIBA 01/2008 - 12/2004
2	AntigensIBA 01/2008 - 10/2006
2	Methotrexate (Mexate)FDA LinkGeneric 01/2008 - 07/2002
2	Immunoglobulin G (IgG)IBA 08/2007 - 05/2002
2	AntibodiesIBA 08/2007 - 05/2002
2	Busulfan (Busulfex)FDA Link 10/2006 - 12/2004
2	Methylprednisolone FDA LinkGeneric 10/2006 - 07/2002
2	Thomsen-Friedenreich antibodiesIBA 10/2006 - 12/2004
2	GlobulinsIBA 10/2006 - 12/2004
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2003 - 03/2003
2	WT1 ProteinsIBA 07/2002 - 05/2002
1	Toll-Like Receptor 7IBA 10/2023
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 01/2023
1	mRNA VaccinesIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	BNT162 VaccineIBA 11/2022
1	Prostaglandins GIBA 03/2022
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2021
1	CytokinesIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 09/2012
1	TOR Serine-Threonine KinasesIBA 09/2012
1	Proteins (Proteins, Gene)FDA Link 09/2012
1	Interleukin-7 (Interleukin 7)IBA 05/2011
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2008
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2008
1	Immunoglobulin A (IgA)IBA 08/2007
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2006
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 12/2006
1	Indicators and Reagents (Reagents)IBA 11/2003
1	DNA (Deoxyribonucleic Acid)IBA 07/2002
1	Immunoglobulin IsotypesIBA 05/2002
1	Immunoglobulin M (IgM)IBA 05/2002
1	Immunoglobulins (Immunoglobulin)IBA 05/2002

Therapy/Procedure

4	Immunotherapy 01/2023 - 05/2002
4	Therapeutics 01/2019 - 12/2004
3	Transplantation 10/2006 - 08/2004
3	Stem Cell Transplantation 10/2006 - 03/2003
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2008 - 07/2002
1	Blood Transfusion (Blood Transfusions) 12/2021
1	Duration of Therapy 05/2011
1	Remission Induction 12/2006
1	Homologous Transplantation 03/2003